The Promise of Research
No two bladder cancer cases are alike, which is why the Johns Hopkins Greenberg Bladder Cancer Institute team takes an individualized approach with each patient. Our investigators are committed to improving the lives of bladder cancer patients and believe that clinical trials are critical to realizing that goal. Within the Greenberg Institute, clinical trials are presented as an initial option to all patients. If our multidisciplinary team determines that a clinical trial option is not available for a particular patient, standard of care options always remain a therapy option.
Clinical trials provide patients with access to new bladder cancer treatment approaches in their early stages of discovery. These may include new immunotherapy drugs or surgical techniques, novel protocols for specific cancer stages, or trials to determine the effectiveness of different treatment combinations.
How to Enroll
Many of the studies available at Johns Hopkins are being directed by physicians on the Johns Hopkins Greenberg Institute team, which is dedicated to advancing bladder cancer research. Our team is very knowledgeable about trials and collaborates with many other clinical trial enrollments.
Our multi-disciplinary team of experts will discuss the pros and cons of a particular trial and whether you meet eligibility requirements. They will be with you from inception and through the clinical trial journey.
Find a Clinical Trial
View current trials offered at the Johns Hopkins Kimmel Cancer Center for bladder cancer patients.
Navigating Clinical Trials in Bladder Cancer
Benefactor Stephanie Cooper Greenberg joins Johns Hopkins Greenberg Bladder Cancer Institute specialists David McConkey, Ph.D., Noah Hahn, M.D., Jean Hoffman-Censits, M.D., and Max Kates, M.D., to provide guidance in navigating the complex landscape of clinical trials for bladder cancer at a May 11, 2018 program for patients and caregivers.